Hyperplastic Polyposis Syndrome: Colorectal Cancer Predisposition

作者: Joanne Young

DOI: 10.1007/978-1-4419-6603-2_6

关键词:

摘要: A major paradigm shift in the way we view initiation and progression of colorectal cancer (CRC) has occurred within last decade. For many years, malignant transformation adenomatous polyps (adenomas) was considered to be only route human colon. The other common polyp type, with serrated but non-dysplastic features (also referred as hyperplastic or metaplastic polyps) seen innocuous. However, recognition at a molecular level that some may act precursor lesions for CRCs, “serrated pathway” came age, provided an alternative mechanism development CRC, existing alongside traditional adenoma–carcinoma sequence. Molecular evidence first observed patient condition called polyposis syndrome (HPS), where multiple are present throughout Since this pivotal event, HPS served model pathway CRC development, analogous by FAP sporadic In chapter, individuals have genetic predisposition, which increases their risk developing will examined. Though lesion underlying is yet identified, its inclusion predisposition concept whose time come.

参考文章(112)
Jeremy Jass, Susan Parry, Julie Arnold, Joanne Young, Andrew Yeoman, Hyperplastic polyposis in the New Zealand population: a condition associated with increased colorectal cancer risk and European ancestry. The New Zealand Medical Journal. ,vol. 120, ,(2007)
Fogt F, Glick Me, Warner As, Multiple large hyperplastic polyps of the colon coincident with adenocarcinoma. The American Journal of Gastroenterology. ,vol. 89, pp. 123- 125 ,(1994)
Lauri A. Aaltonen, Stanley R. Hamilton, Pathology and genetics of tumours of the digestive system IARC Press. ,(2000)
Nathan Lane, The precursor tissue of ordinary large bowel cancer. Cancer Research. ,vol. 36, pp. 2669- 2672 ,(1976)
Jörg Matthes, Christian Schemer, Werner Wirth, More than meets the eye: Investigating the hidden impact of brand placements in television magazines International Journal of Advertising. ,vol. 26, pp. 477- 503 ,(2007) , 10.1080/02650487.2007.11073029
Bharati V. Bapat, Angela Mitri, Hartley S. Stern, Kazy Hay, Steven Gallinger, Andrew J. Smith, Mark Penner, Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Research. ,vol. 54, pp. 5527- 5530 ,(1994)
Antti Kokko, Päivi Laiho, Rainer Lehtonen, Sanna Korja, Luis G Carvajal-Carmona, Heikki Järvinen, Jukka-Pekka Mecklin, Charis Eng, Johanna Schleutker, Ian PM Tomlinson, Pia Vahteristo, Lauri A Aaltonen, EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis BMC Cancer. ,vol. 6, pp. 145- 145 ,(2006) , 10.1186/1471-2407-6-145
Hagen Blaszyk, Eva Klopocki, Wolfgang Dietmaier, Neil H. Hyman, Edgar Dahl, Arndt Hartmann, Barbara G. Beatty, Barbara I. Oberschmid, Distinct secreted Frizzled receptor protein 1 staining pattern in patients with hyperplastic polyposis coli syndrome. Archives of Pathology & Laboratory Medicine. ,vol. 128, pp. 967- 973 ,(2004) , 10.1043/1543-2165(2004)128<967:DSFRPS>2.0.CO;2
P. JEEVARATNAM, D. S. COTTIER, P. J. BROWETT, N. S. VAN DE WATER, V. POKOS, J. R. JASS, Familial giant hyperplastic polyposis predisposing to colorectal cancer: A new hereditary bowel cancer syndrome The Journal of Pathology. ,vol. 179, pp. 20- 25 ,(1996) , 10.1002/(SICI)1096-9896(199605)179:1<20::AID-PATH538>3.0.CO;2-C
Michael D. Walsh, Daniel D. Buchanan, Rhiannon Walters, Aedan Roberts, Sven Arnold, Diane McKeone, Mark Clendenning, Andrew R. Ruszkiewicz, Mark A. Jenkins, John L. Hopper, Jack Goldblatt, Jillian George, Graeme K. Suthers, Kerry Phillips, Graeme P. Young, Finlay Macrae, Musa Drini, Michael O. Woods, Susan Parry, Jeremy R. Jass, Joanne P. Young, Analysis of Families with Lynch Syndrome Complicated by Advanced Serrated Neoplasia: The Importance of Pathology Review and Pedigree Analysis Familial Cancer. ,vol. 8, pp. 313- 323 ,(2009) , 10.1007/S10689-009-9238-8